VALENCE THERAPEUTICS Trademark

Trademark Overview


On Sunday, July 6, 2025, a trademark application was filed for VALENCE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the VALENCE THERAPEUTICS trademark a serial number of 99269320. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, November 26, 2025. The VALENCE THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical research services; Pharmaceutical product evaluation; Pharmaceutical products development; Research and development services of new pharmaceutical products; Research and development in the pharmaceutical and biotechnology fields; Consulting services in the field of pharmaceutical research and development

Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical products for the prevention and treatment of cancer
valence therapeutics

General Information


Serial Number99269320
Word MarkVALENCE THERAPEUTICS
Filing DateSunday, July 6, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, November 26, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical research services; Pharmaceutical product evaluation; Pharmaceutical products development; Research and development services of new pharmaceutical products; Research and development in the pharmaceutical and biotechnology fields; Consulting services in the field of pharmaceutical research and development
Goods and ServicesPharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical products for the prevention and treatment of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, July 6, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, July 6, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressBoston, MA 02114-4113

Trademark Events


Event DateEvent Description
Sunday, July 6, 2025NEW APPLICATION ENTERED
Monday, July 7, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, November 11, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 24, 2025ASSIGNED TO EXAMINER
Wednesday, November 26, 2025NON-FINAL ACTION WRITTEN
Wednesday, November 26, 2025NON-FINAL ACTION E-MAILED
Wednesday, November 26, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED